Structural and functional studies of the TRPM2 channel
TRPM2通道的结构和功能研究
基本信息
- 批准号:10413415
- 负责人:
- 金额:$ 9.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adenosine Diphosphate RiboseAgonistAlzheimer&aposs DiseaseApoptosisBindingBinding SitesBiologicalBiological AssayBody TemperatureBrainBrain InjuriesC-terminalCalciumCardiovascular systemCell DeathCell membraneCell physiologyCellsCharacteristicsCoiled-Coil DomainComplexConsensusCryoelectron MicroscopyCurcuminCyclic ADP-RiboseDataDevelopmentDiabetes MellitusElectrophysiology (science)FamilyFamily memberFeverFoundationsHomologous GeneHumanImmuneImmune responseInflammationIon ChannelIon Channel ProteinIonsKnowledgeLinkLysosomesMetabolismMissionMitochondriaMolecularMolecular StructureN-terminalNerveNeurodegenerative DisordersNucleotidesOxidative StressPathologicPermeabilityPharmaceutical PreparationsPharmacologyPhysiologic ThermoregulationPhysiological ProcessesPlayProtonsPublic HealthResearchResearch Project GrantsRhizomeRoleSolidStrokeStructureTissuesTumericUnited States National Institutes of HealthVascular Smooth MuscleWorkX-Ray CrystallographyZebrafishexperimental studyinsulin secretioninterdisciplinary approachnovelnovel therapeuticsparticlepreventpyrophosphatasereceptorsimulationsulfated glycoprotein 2
项目摘要
Project Summary
Body temperature is strictly maintained in a narrow range to protect the delicate nerves in the brain and other
body tissues, because improper body temperature gives rise to fever, brain injury, and stroke. TRPM2 is the
major warmth-sensing receptor in the brain regulating core body temperature and preventing overheating as
fever occurs. TRPM2 is a Ca2+-permeable, nonselective ion channel that is highly expressed in brain but is
also found in the heart, vascular and smooth muscle, and immune cells. It is uniquely activated by Ca2+ and
ADP ribose (ADPR), a product of the metabolism of NAD+ and a secondary messenger released upon
oxidative stress. The activation of TRPM2 results in both Ca2+ entry across the plasma membrane and Ca2+
release from lysosomes. Therefore, TRPM2 plays fundamental role in Ca2+-dependent array of physiological
processes and cellular functions from insulin secretion to immune response to cell death. It has been
implicated in Alzheimer disease, stroke, and other neurodegenerative diseases.
TRPM2 belongs to the TRPM (melastatin-like transient receptor potential) subfamily of the TRP superfamily.
Despite sharing the characteristic TRPM N-terminal homology regions (MHRs) and C-terminal coiled-coil
domains, TRPM2 is uniquely assembled with a C-terminal NHDT9-H domain, a homolog to the human
mitochondrial ADP-ribose pyrophosphatase NUDT9. Functional studies, including binding assays,
electrophysiology, and molecular simulations, provided a consensus view that ADPR binds to the NUDT9-H
domain, but proof of the ADPR binding site is lacking, and the molecular basis for the action of the agonist
ADPR on TRPM2 in the presence of calcium remains unknown. The gating of TRPM2 is further modulated
by many molecules and ions that range from protons to nucleotides (cyclic ADPR, AMP, 8-Br-cADPR) to
curcumin (which is isolated from rhizomes of Curcuma longa), acting by way of multiple mechanisms. At
present, we don’t know where these molecules and ions bind to TRPM2 or how they activate the channel or
modulate its function.
We have obtained two cryo-EM structures of zebrafish TRPM2 in the apo/closed and ADPR/Ca2+-bound open
state, with the latter representing the first active state of TRPM family members. We identified a novel ADPR
binding site that is located outside the NUDT9-H domain and was completely unknown before. Building on
this preliminary data, we propose to continue the structural studies of TRPM2 combined with complementary
electrophysiology experiments, binding assays, and X-ray crystallography, which will define the molecular
basis for a comprehensive gating mechanism and pharmacology. These advances will provide a solid
foundation for developing new drugs against neurodegenerative diseases and for a deeper understanding
the function of the entire TRPM family.
项目摘要
体温严格保持在一个狭窄的范围内,以保护大脑和其他神经系统中的脆弱神经。
身体组织,因为不适当的体温会引起发烧,脑损伤和中风。TRPM 2是
大脑中主要的温度感应受体,调节核心体温,防止过热,
出现发热。TRPM 2是一种Ca 2+可渗透的非选择性离子通道,在脑中高度表达,但在脑中表达不明显。
也存在于心脏、血管和平滑肌以及免疫细胞中。它被Ca 2+唯一激活,
ADP核糖(ADPR)是NAD+代谢的产物,是NAD+代谢后释放的第二信使。
氧化应激TRPM 2的激活导致Ca 2+穿过质膜进入细胞,
从溶酶体中释放。因此,TRPM 2在Ca 2+依赖的生理性细胞凋亡中起着重要作用。
从胰岛素分泌到对细胞死亡的免疫反应的过程和细胞功能。已经
与阿尔茨海默病、中风和其他神经退行性疾病有关。
TRPM 2属于TRP超家族的TRPM(melastin-like transient receptor potential)亚家族。
尽管共有TRPM N-末端同源区(MHR)和C-末端卷曲螺旋区,
结构域,TRPM 2独特地与C-末端NHDT 9-H结构域组装,NHDT 9-H结构域是人TRPM 2的同源物。
线粒体ADP-核糖焦磷酸酶NUDT 9.功能研究,包括结合试验,
电生理学和分子模拟,提供了一个共识的观点,ADPR结合NUDT 9-H
结构域,但缺乏ADPR结合位点的证据,激动剂作用的分子基础
在钙存在下TRPM 2上的ADPR仍然未知。TRPM 2的门控被进一步调节,
许多分子和离子,从质子到核苷酸(环ADPR,AMP,8-Br-cADPR),
姜黄素(从姜黄的根茎中分离),通过多种机制起作用。在
目前,我们不知道这些分子和离子在哪里与TRPM 2结合,或者它们如何激活通道,
调节其功能。
我们获得了斑马鱼TRPM 2在apo/封闭和ADPR/Ca ~(2+)-结合的开放两种冷冻电镜结构
状态,后者代表TRPM家族成员的第一个活跃状态。我们发现了一种新的ADPR
结合位点位于NUDT 9-H结构域之外,以前完全未知。基础上
根据这些初步数据,我们建议继续进行TRPM 2的结构研究,
电生理学实验,结合分析和X射线晶体学,这将定义分子
为全面的门控机制和药理学奠定基础。这些进步将提供一个坚实的
基金会,用于开发针对神经退行性疾病的新药,并加深对神经退行性疾病的了解
整个TRPM家族的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juan Du其他文献
Akt regulates the fertility of Coridius chinensis by insulin signaling pathway
阿克泰通过胰岛素信号通路调控中华稻蝗的生殖力
- DOI:
10.1038/s41598-024-78416-0 - 发表时间:
2024-11-20 - 期刊:
- 影响因子:3.900
- 作者:
Jinyu Feng;Juan Du;Shangwei Li;Xingxing Chen - 通讯作者:
Xingxing Chen
Juan Du的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juan Du', 18)}}的其他基金
Structural Basis of Nociceptor Channel TRPM3 gating and pharmacology
伤害感受器通道 TRPM3 门控和药理学的结构基础
- 批准号:
10735377 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
Deep-learning methods based computational modeling
基于深度学习方法的计算建模
- 批准号:
10816248 - 财政年份:2022
- 资助金额:
$ 9.82万 - 项目类别:
Activation and Inhibition Mechanisms of Calcium-Activated Nonselective Cation Channels
钙激活非选择性阳离子通道的激活和抑制机制
- 批准号:
10629410 - 财政年份:2022
- 资助金额:
$ 9.82万 - 项目类别:
Activation and Inhibition Mechanisms of Calcium-Activated Nonselective Cation Channels
钙激活非选择性阳离子通道的激活和抑制机制
- 批准号:
10503201 - 财政年份:2022
- 资助金额:
$ 9.82万 - 项目类别:
Structural and functional studies of the TRPM2 channel
TRPM2通道的结构和功能研究
- 批准号:
10604261 - 财政年份:2019
- 资助金额:
$ 9.82万 - 项目类别:
Structural and functional studies of the TRPM2 channel
TRPM2通道的结构和功能研究
- 批准号:
9896879 - 财政年份:2019
- 资助金额:
$ 9.82万 - 项目类别:
Structural and functional studies of the TRPM2 channel
TRPM2通道的结构和功能研究
- 批准号:
10386771 - 财政年份:2019
- 资助金额:
$ 9.82万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 9.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 9.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 9.82万 - 项目类别:














{{item.name}}会员




